THEAIFA, the Italian Medicines Agency, gave his green light for the vaccine mix so whoever took the first dose of AstraZeneca can receive the second dose with an mRna vaccine. The only two vaccines of this type at the moment are Pfizer and Modern and, after the doubts that arose on AstraZeneca, especially on young people due to the death of an 18-year-old, it was decided to change strategy again.
In fact, the Anglo-Swedish vaccine will only be administered to the over 60s, while from the age of 59 and under other vaccines will be administered. Younger people especially will not receive viral vector vaccines.
As mentioned, those of the youngest (and under 60 in general) who have already been vaccinated with an AstraZeneca dose will be able to receive the heterologous vaccination, which is the second dose of Pfizer or Moderna.
Greater antibody coverage
With this type of mixed vaccination, according to early studies, there was also a increased antibody response of individuals under 60. Precisely for this reason, "on the basis of clinical studies published in recent weeks, the technical-scientific Commission has considered, compared to a relevant one strengthening antibody response and a good profile of reactogenicity“, To say yes to the vaccine mix.
According to Aifa, the second administration with a different vaccine must take place within 8-12 weeks from the first AstraZeneca dose.
The stop of De Luca in Campania
Il President of the Campania Region Vincenzo De Luca he expressed himself against the mix of vaccines and suspended vaccinations with viral vector vaccines. Even the pharmacies have suspended vaccinations as Johnson & Johnson, the single-dose vaccine available in pharmacies, is also viral-vectored like AstraZeneca.
